← SynDRA
BETAMETHASONE DIPROPIONATE
SynDRA canonical compound SYN0022954 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | NR3C1 |
| Mechanism of action | anti-inflammatory agent |
| Indication | corticosteroid-responsive dermatoses |
| Disease area | dermatology |
All known targets
Mechanisms of action (all sources)
- NR3C1 AGONIST
- anti-inflammatory agent
Drug classes
- Corticosteroid Hormone Receptor Agonists
- Corticosteroid
- Anti-Inflammatory Agents
- Anti-Asthmatic Agents
- Glucocorticoids
- Hormones
- Respiratory System Agents
Cross-references
Synonyms
- diproderm
- diprosone
- Betamethasone 17,21-dipropionate
- Betamethasone (as dipropionate)
- Diprospan
- Maxivate
- Rinderon dp
- NSC-758415
- SCH-11460
- Alphatrex
- Betamethasone dipropionate component of enstilar
- Betamethasone dipropionate component of leo-90100
- Betamethasone dipropionate component of lotrisone
- Betamethasone dipropionate component of taclonex
- Betamethasone dipropionate component of wynzora
- Diprolene
- Diprolene af
- Diprosone
- Sernivo
- Diprolene AF
- Diproderm
- Diprosis
- Psorion
- Rinderon DP
- Sch 11460
- UNII-826Y60901U
- beta-Methasone 17,21-dipropionate
- EINECS 227-005-2
- S 3440
- BRN 3638108
- CHEBI:31276
- CIWBQSYVNNPZIQ-XYWKZLDCSA-N
- 826Y60901U
- 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
- 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-dien
- betamethasone-dipropionate
- betamethasone.dipropionate
- Betamethasone-17,21-dipropionate
Look up BETAMETHASONE DIPROPIONATE in the interactive SynDRA portal →